Vanguard Group’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$9.6M Buy
3,490,658
+52,793
+2% +$151K ﹤0.01% 2983
2025
Q3
$11.8M Buy
3,437,865
+163,532
+5% +$596K ﹤0.01% 2888
2025
Q2
$11.3M Buy
3,274,333
+207,282
+7% +$547K ﹤0.01% 2840
2025
Q1
$6.53M Sell
3,067,051
-77,816
-2% -$234K ﹤0.01% 3068
2024
Q4
$10M Buy
3,144,867
+67,926
+2% +$555K ﹤0.01% 2956
2024
Q3
$41.1M Buy
3,076,941
+155,673
+5% +$2.07M ﹤0.01% 2269
2024
Q2
$29.1M Buy
2,921,268
+1,143,257
+64% +$16.5M ﹤0.01% 2376
2024
Q1
$21.2M Buy
1,778,011
+456,636
+35% +$3.89M ﹤0.01% 2569
2023
Q4
$5.31M Buy
1,321,375
+39,512
+3% +$111K ﹤0.01% 3266
2023
Q3
$3.51M Buy
1,281,863
+9,919
+0.8% +$46.3K ﹤0.01% 3397
2023
Q2
$8.5M Buy
1,271,944
+71,999
+6% +$437K ﹤0.01% 3039
2023
Q1
$7.66M Buy
1,199,945
+594,865
+98% +$2.43M ﹤0.01% 3089
2022
Q4
$1.5M Buy
605,080
+298
+0% +$982 ﹤0.01% 3776
2022
Q3
$1.39M Hold
604,782
﹤0.01% 3886
2022
Q2
$1.87M Hold
604,782
﹤0.01% 3834
2022
Q1
$2.2M Sell
604,782
-1,837
-0.3% -$6.7K ﹤0.01% 3918
2021
Q4
$2.35M Sell
606,619
-5,432
-0.9% -$29K ﹤0.01% 3981
2021
Q3
$3.86M Hold
612,051
﹤0.01% 3806
2021
Q2
$4.88M Sell
612,051
-8,787
-1% -$77K ﹤0.01% 3618
2021
Q1
$6.77M Buy
620,838
+341,341
+122% +$5.16M ﹤0.01% 3369
2020
Q4
$1.26M Sell
279,497
-78
-0% -$345 ﹤0.01% 3772
2020
Q3
$1.63M Buy
279,575
+40,666
+17% +$265K ﹤0.01% 3544
2020
Q2
$1.33M Hold
238,909
﹤0.01% 3542
2020
Q1
$1.27M Buy
238,909
+79,360
+50% +$599K ﹤0.01% 3432
2019
Q4
$996K Sell
159,549
-1,420
-0.9% -$6.23K ﹤0.01% 3641
2019
Q3
$516K Buy
160,969
+1,478
+0.9% +$5.35K ﹤0.01% 3813
2019
Q2
$654K Buy
159,491
+16,910
+12% +$70.9K ﹤0.01% 3780
2019
Q1
$520K Buy
142,581
+480
+0.3% +$1.87K ﹤0.01% 3757
2018
Q4
$426K Sell
142,101
-43,626
-23% -$187K ﹤0.01% 3765
2018
Q3
$964K Buy
185,727
+36,733
+25% +$205K ﹤0.01% 3731
2018
Q2
$670K Sell
148,994
-1,514
-1% -$7.01K ﹤0.01% 3779
2018
Q1
$633K Sell
150,508
-4,670
-3% -$20.6K ﹤0.01% 3743
2017
Q4
$619K Hold
155,178
﹤0.01% 3697
2017
Q3
$801K Sell
155,178
-3,919
-2% -$22K ﹤0.01% 3646
2017
Q2
$994K Sell
159,097
-30,274
-16% -$171K ﹤0.01% 3569
2017
Q1
$1.12M Hold
189,371
﹤0.01% 3549
2016
Q4
$1.1M Sell
189,371
-6,724
-3% -$41.1K ﹤0.01% 3526
2016
Q3
$1.41M Sell
196,095
-4,743
-2% -$36.1K ﹤0.01% 3489
2016
Q2
$1.75M Sell
200,838
-703
-0.3% -$6.73K ﹤0.01% 3416
2016
Q1
$1.81M Sell
201,541
-910
-0.4% -$7.17K ﹤0.01% 3415
2015
Q4
$1.9M Buy
202,451
+909
+0.5% +$11.3K ﹤0.01% 3413
2015
Q3
$2.82M Hold
201,542
﹤0.01% 3219
2015
Q2
$2.98M Sell
201,542
-1,352
-0.7% -$21.9K ﹤0.01% 3240
2015
Q1
$3.19M Sell
202,894
-2,420
-1% -$35.9K ﹤0.01% 3208
2014
Q4
$3M Buy
205,314
+14,690
+8% +$233K ﹤0.01% 3127
2014
Q3
$3.22M Buy
190,624
+32,718
+21% +$810K ﹤0.01% 3067
2014
Q2
$4.93M Buy
157,906
+44,290
+39% +$1.11M ﹤0.01% 2838
2014
Q1
$2.5M Buy
113,616
+68,352
+151% +$695K ﹤0.01% 3121
2013
Q4
$226K Buy
45,264
+40
+0.1% +$211 ﹤0.01% 3744
2013
Q3
$294K Buy
45,224
+3,410
+8% +$21.3K ﹤0.01% 3639
2013
Q2
$201K Buy
+41,814
New +$225K ﹤0.01% 3635

Other funds holding CATX